Abstract
Introduction: AIDS is a deadly disease and is leading cause of morbidity in today's population .EPTB is one of most common opportunistic infection associated with AIDs and cervical lymphadenopathy is most common among them . CD4+ cells in our body plays an important role in treatment outcome of AIDS patients and is marker of good immunity. This is a retrospective ana Materials And Methods: lysis conducted in a tertiary centre in the Department of Otorhinolaryngology & head and neck surgery from January 2020 to December 2020. A total of 80 patients were studied for 1 year. Conrmed cases of AIDS with extra pulmonary tuberculosis in head and neck region were studied, keeping all ethical issues in mind and there CD4+ counts were followed up for 3, 6 and 12 weeks. All patients under stu Results: dy were given HAART and ATT simultaneously, 69 % patients have cervical lymphadenopathy as the most common site of extrapulmonary tuberculosis, and CD4+ cells >500 cells/mm3 at the time of diagnosis proved to respond better to therapy. Also 84 % patients are resolved with EPTB after the treatment. Conclusion: Start ATT along with HAART as soon as possible to improve quality of life of the patient. Serial monitoring of cells is beneciary for monitoring the prognosis of disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
